首页> 外文期刊>Oncology letters >High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder
【24h】

High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder

机译:B7-H3和CD163在癌组织中的高表达表明膀胱尿路上皮细胞癌的恶性临床病理状态和预后差

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of the present study was to investigate the association of B7-H3 expression and cluster of differentiation (CD) 163+ tumor-associated macrophage (TAM) infiltration with clinicopathological parameters in urothelial cell carcinoma of the bladder (UCB), and to investigate their potential conjoint effects on progression of UCB. B7-H3 expression and CD163+ TAM infiltration in tumor specimens from 134 consecutive patients that underwent radical cystectomy for UCB were tested using immunohistochemistry, followed by statistical analysis. In these 134 patients, B7-H3 expression and CD163+ TAM infiltration in the bladder carcinoma tissues were significantly associated with an increased ratio of vascular invasion (P=0.009; P=0.012) and distant metastasis (P=0.015; P=0.038); however, they were not associated with gender, age, pathologic grade, tumor stage, recurrence or lymphatic metastasis. The results of chi(2) test analysis indicated that CD163(+) TAM infiltration and B7-H3 expression were positively correlated (chi(2)=20.714; P<0.001). Overall survival (OS) and progression-free survival (PFS) rates were significantly worsened by high B7-H3 expression (P=0.002; P=0.020). However, CD163+ TAM infiltration was not associated with OS or PFS rate. Notably, the OS and PFS rates in patients with high B7-H3 expression or high CD163+ TAM infiltration were significantly poorer than the patients with low B7-H3 expression (P<0.001; P<0.001) or low CD163+ TAM infiltration (P=0.022; P=0.017) in the subgroup of 115 patients with muscle-invasive bladder cancer. The results of the present study indicate that B7-H3 expression level could be used as an independent prognostic indicator following radical cystectomy for UCB and patients with high B7-H3 expression and high CD163+ TAM infiltration experience a poorer prognosis.
机译:本研究的目的是研究B7-H3表达和分化簇(CD)163+肿瘤相关巨噬细胞(TAM)浸润与膀胱(UCB)的尿路上皮细胞癌中的临床病理参数的关联,并调查他们对UCB进展的潜在联合影响。使用免疫组织化学测试从134个连续患者的肿瘤标本表达和CD163 + TAM渗透,从而进行了对UCB进行了自由基膀胱切除术,然后进行统计分析。在这些134名患者中,B7-H3表达和CD163 + TAM浸润在膀胱癌组织中与血管侵袭的比例显着相关(p = 0.009; p = 0.012)和远处转移(p = 0.015; p = 0.038);然而,它们与性别,年龄,病理成绩,肿瘤阶段,复发或淋巴转移无关。 CHI(2)试验分析结果表明CD163(+)TAM浸润和B7-H3表达正相关(CHI(2)= 20.714; p <0.001)。通过高B7-H 3表达显着恶化,总存活(OS)和无进展存活率(P = 0.002; P = 0.020)。然而,CD163 + TAM渗透与OS或PFS率无关。值得注意的是,高B7-H3表达或高CD163 + TAM浸润患者的OS和PFS率比低B7-H3表达的患者显着差(P <0.001; p <0.001)或低CD163 + TAM浸润(P = 0.022 ; P = 0.017)在115例肌肉侵袭性膀胱癌的患者的亚组中。本研究的结果表明,B7-H3表达水平可用作自由基膀胱切除术后的UCB和高B7-H3表达的患者和高CD163 + TAM浸润的患者的预后较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号